Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients

American Journal of Medicine

Volumn 118, Issue 12, 2005, Pages 1373-1380

  Lentine, Krista L ^a   Flavin, Kara E ^b   Gould, Michael K ^b,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deep venous thrombosis; Intensive care unit; Pulmonary embolism; Venous thromboembolism; Venous thromboembolism prophylaxis

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; APACHE; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRITICAL ILLNESS; DEEP VEIN THROMBOSIS; DEMOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; THROMBOSIS PREVENTION; UNIVERSITY HOSPITAL;

AGED; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HOSPITALS, UNIVERSITY; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM;

EID: 29244474905     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.12.025     Document Type: Article

References (31)

1. W.H. Geerts, J.A. Heit, G.P. Clagett Prevention of venous thromboembolism Chest 119 2001 132S 175S
2. G. Agnelli, F. Sonaglia Prevention of venous thromboembolism Thromb Res 97 2000 V49 V62
3. B. Lindblad, N.H. Sternby, D. Bergqvist Incidence of venous thromboembolism verified by necropsy over 30 years BMJ 302 1991 709 711
4. D.A. Sandler, J.F. Martin Autopsy proven pulmonary embolism in hospital patients are we detecting enough deep vein thrombosis? J R Soc Med 82 1989 203 205
5. S.K. Pingleton, A. Rossi Respiratory and non-respiratory complications of critical illness J.E.B.R. Parillo Critical care medicine principles of diagnosis and management 1995 Mosby St. Louis 782 783
6. D. Cook, J. Attia, B. Weaver Venous thromboembolic disease an observational study in medical-surgical intensive care unit patients J Crit Care 15 2000 127 132
7. J.F. Cade High risk of the critically ill for venous thromboembolism Crit Care Med 10 1982 448 450
8. P.E. Marik, L. Andrews, B. Maini The incidence of deep venous thrombosis in ICU patients Chest 111 1997 661 664
9. M.M. Knudson, J.A. Collins, S.B. Goodman, D.W. McCrory Thromboembolism following multiple trauma J Trauma 32 1992 2 11
10. W.H. Geerts, K.I. Code, R.M. Jay A prospective study of venous thromboembolism after major trauma N Engl J Med 331 1994 1601 1606
11. M.G. Keane, E.P. Ingenito, S.Z. Goldhaber Utilization of venous thromboembolism prophylaxis in the medical intensive care unit Chest 106 1994 13 14
12. R.P. Ryskamp, S.J. Trottier Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU Chest 113 1998 162 164
13. W.A. Knaus, E.A. Draper, D.P. Wagner, J.E. Zimmerman APACHE II a severity of disease classification system Crit Care Med 13 1985 818 829
14. M. Katz Multivariable Analysis a Practical Guide for Clinicians 1999 Cambridge University Press New York 118-125
15. H.L. Corwin, A. Gettinger, R.G. Pearl Efficacy of recombinant human erythropoietin in critically ill patients a randomized controlled trial JAMA 288 2002 2827 2835
16. R. Collins, A. Scrimgeour, S. Yusuf, R. Peto Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin Overview of results of randomized trials in general, orthopedic, and urologic surgery N Engl J Med 318 1988 1162 1173
17. A. Leizorovicz, M.C. Haugh, F.R. Chapuis Low molecular weight heparin in prevention of perioperative thrombosis BMJ 305 1992 913 920
18. M.T. Nurmohamed, F.R. Rosendaal, H.R. Buller Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery a meta-analysis Lancet 340 1992 152 156
19. G.P. Clagett, J.S. Reisch Prevention of venous thromboembolism in general surgical patients Results of meta-analysis Ann Surg 208 1988 227 240
20. Prevention of fatal postoperative pulmonary embolism by low doses of heparin An international multicentre trial Lancet 2 1975 45 51
21. M.M. Samama, A.T. Cohen, J.Y. Darmon A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 341 1999 793 800
22. H. Halkin, J. Goldberg, M. Modan, B. Modan Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis Ann Intern Med 96 1982 561 565
23. W. Geerts, R. Selby Prevention of venous thromboembolism in the ICU Chest 124 2003 357S 363S
24. D. Cook, J. McMullin, R. Hodder Prevention and diagnosis of venous thromboembolism in critically ill patients a Canadian survey Crit Care 5 2001 336 342
25. B. Gardlund The Heparin Prophylaxis Study Group Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases Lancet 347 1996 1357 1361
26. F. Fraisse, L. Holzapfel, J.M. Couland The Association of Non-University Affiliated Intensive Care Specialist Physicians of France Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD Am J Respir Crit Care Med 161 2000 1109 1114
27. D.R. Hirsch, E.P. Ingenito, S.Z. Goldhaber Prevalence of deep venous thrombosis among patients in medical intensive care JAMA 274 1995 335 337
28. T.I. Morgenthaler, J.H. Ryu Clinical characteristics of fatal pulmonary embolism in a referral hospital Mayo Clin Proc 70 1995 417 424
29. A.F. Shorr, R.F. Trotta, S.A. Alkins D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease Intensive Care Med 25 1999 207 210
30. B.L. Davidson, W.H. Geerts, A.W. Lensing Low-dose heparin for severe sepsis N Engl J Med 347 2002 1036 1037
31. E. Abraham, K. Reinhart, S. Opal Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis a randomized controlled trial [Letter] JAMA 290 2003 238 247